Nektar Therapeutics news

   Watch this stock
Showing stories 1 - 1 of about 1   

Articles published

NKTR 11.09 +0.18 (1.65%)
price chart
Leading Anti-Cancer Drugs and Associated Market 2012-2022
It lets you assess potential sales trends at world market, therapeutic submarket, product and national level to 2022. How will 25 leading products - including Avastin, Rituxan, Herceptin and Glivec/Gleevec - perform from 2012?